NO174421C - Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelsen 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)-dibenzo(b,f)(1,4)tiazepin - Google Patents

Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelsen 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)-dibenzo(b,f)(1,4)tiazepin

Info

Publication number
NO174421C
NO174421C NO881044A NO881044A NO174421C NO 174421 C NO174421 C NO 174421C NO 881044 A NO881044 A NO 881044A NO 881044 A NO881044 A NO 881044A NO 174421 C NO174421 C NO 174421C
Authority
NO
Norway
Prior art keywords
thiazepine
dibenzo
hydroxyethoxy
piperazinyl
ethyl
Prior art date
Application number
NO881044A
Other languages
English (en)
Other versions
NO881044L (no
NO881044D0 (no
NO174421B (no
Inventor
Alan Charles Barker
Robert Jeffrey Copeland
Original Assignee
Zeneca Ltd
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd, Ici Plc filed Critical Zeneca Ltd
Publication of NO881044D0 publication Critical patent/NO881044D0/no
Publication of NO881044L publication Critical patent/NO881044L/no
Publication of NO174421B publication Critical patent/NO174421B/no
Publication of NO174421C publication Critical patent/NO174421C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO881044A 1987-03-10 1988-03-09 Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelsen 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)-dibenzo(b,f)(1,4)tiazepin NO174421C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878705574A GB8705574D0 (en) 1987-03-10 1987-03-10 Preparation of thiazepine compound

Publications (4)

Publication Number Publication Date
NO881044D0 NO881044D0 (no) 1988-03-09
NO881044L NO881044L (no) 1988-09-12
NO174421B NO174421B (no) 1994-01-24
NO174421C true NO174421C (no) 1994-05-04

Family

ID=10613643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881044A NO174421C (no) 1987-03-10 1988-03-09 Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelsen 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)-dibenzo(b,f)(1,4)tiazepin

Country Status (25)

Country Link
EP (1) EP0282236B1 (no)
JP (1) JPH0688991B2 (no)
KR (1) KR960007088B1 (no)
AR (1) AR245707A1 (no)
AT (1) ATE70271T1 (no)
AU (1) AU595099B2 (no)
CA (1) CA1337345C (no)
DD (1) DD271703A5 (no)
DE (1) DE3866735D1 (no)
DK (1) DK175310B1 (no)
ES (1) ES2037822T3 (no)
FI (1) FI87778C (no)
GB (2) GB8705574D0 (no)
GR (1) GR3003324T3 (no)
HU (1) HU202231B (no)
IE (1) IE61122B1 (no)
IL (1) IL85564A (no)
MW (1) MW388A1 (no)
MY (1) MY103221A (no)
NO (1) NO174421C (no)
NZ (1) NZ223813A (no)
PH (1) PH25529A (no)
PT (1) PT86934B (no)
ZA (1) ZA881350B (no)
ZW (1) ZW2188A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0396581B1 (de) * 1987-12-15 1992-01-15 Siemens Aktiengesellschaft Verfahren zur herstellung von drähten oder bändern aus hochtemperatur-supraleitern und dabei verwendeter hüllkörper
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
GB9716161D0 (en) 1997-08-01 1997-10-08 Zeneca Ltd Process
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
WO2003080065A1 (en) * 2002-03-20 2003-10-02 Teva Pharmaceutical Industries Ltd. Crystalline forms of quetiapine hemifumarate
KR100707050B1 (ko) 2002-11-28 2007-04-13 에스케이 주식회사 10Ｈ-디벤조[ｂ,ｆ][1,4]티아제핀-11-온의 제조방법
WO2004076431A1 (en) * 2003-02-22 2004-09-10 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
WO2004089957A1 (en) 2003-04-07 2004-10-21 Hetero Drugs Limited A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) * 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
DE602004031129D1 (de) 2003-09-23 2011-03-03 Fermion Oy Verfahren zur herstellung von quetiapin
PL368245A1 (en) * 2004-05-28 2005-12-12 CELON PHARMA Sp.z o.o. Method for manufacture of quetiapine
KR101038389B1 (ko) * 2004-06-23 2011-06-01 에스케이바이오팜 주식회사 11-(4-[2-(2-히드록시에톡시)에틸]-1-피페라지닐)-디벤조[ｂ,ｆ][1,4]티아제핀의 제조방법
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
WO2006077602A1 (en) * 2005-01-24 2006-07-27 Ipca Laboratories Limited INDUSTRIAL PREPARATION OF 11-[4-{2-(2-HYDROXYETHOXY ETHYL}-1-PIPERAZINYL] DIBENZO [b,f]-1[1, 4] THIAZEPINE
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
JP2008502707A (ja) 2005-04-14 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド クエチアピンフマレートの調製方法
WO2006135544A1 (en) * 2005-06-10 2006-12-21 Cambrex Charles City, Inc. SYNTHESIS OF 11-(4[-(2-HYDROXYETHOXY)ETHYL]-PIPERAZINYL)-DIBENZO[b,f][1,4]THIAZEPINE AND ITS FUMARATE SALT
WO2007004234A1 (en) * 2005-07-04 2007-01-11 Usv Limited A PROCESS FOR THE PREPARATION OF 2-[2-(4-DIBENZO[b,f] [L,4] THIAZEPIN-11-yl-1- PIPERAZINYL)ETHOXY] ETHANOL FUMARATE
GB0516603D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Processes for the preparation of organic compounds useful as serotonin receptor antagonists
WO2007048870A1 (en) * 2005-10-28 2007-05-03 Fermion Oy Quetiapine hemifumarate purification by crystallization
US20080287418A1 (en) 2007-05-16 2008-11-20 Astrazeneca Ab Extended Release Compositions and Methods for Their Manufacture
WO2009095529A1 (en) 2008-01-31 2009-08-06 Fermion Oy A process for the preparation of quetiapine
PE20110029A1 (es) 2008-06-20 2011-02-11 Astrazeneca Ab Derivados de dibenzotiazepina
DK2262486T3 (da) 2008-08-01 2013-03-25 Krka Tovarna Zdravil D D Novo Mesto Quetiapin sammensætning
EP2153834A3 (en) 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
CN101676275B (zh) * 2008-09-17 2014-05-07 北京德众万全药物技术开发有限公司 一种富马酸喹硫平的制备方法
WO2010089259A2 (en) 2009-02-04 2010-08-12 Woerwag R&D Gmbh Sustained release composition containing quetiapine
JP2012519683A (ja) 2009-03-04 2012-08-30 ランバクシー ラボラトリーズ リミテッド フマル酸クエチアピンの調製方法
WO2011121602A1 (en) 2010-03-29 2011-10-06 Hikal Limited Process for preparation of dibenzothiazepinone compounds
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
EP2848244A1 (en) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Extended release tablet formulations of quetiapine
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
CN104016945B (zh) * 2014-05-27 2016-06-29 渭南畅通药化科技有限公司 一种半富马酸喹硫平的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792426A (fr) * 1971-12-09 1973-06-07 Wander Ag Dr A Nouveaux derives de la dibenzo(b,f)(1,4)thiazepine, leur preparation etleur application comme medicaments
JPS60155171A (ja) * 1983-12-10 1985-08-15 Wako Pure Chem Ind Ltd ポリメトキシベンジルピペラジン誘導体
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds

Also Published As

Publication number Publication date
FI881087A0 (fi) 1988-03-09
MW388A1 (en) 1988-10-12
KR960007088B1 (ko) 1996-05-27
ZW2188A1 (en) 1989-10-04
FI87778C (fi) 1993-02-25
DE3866735D1 (de) 1992-01-23
MY103221A (en) 1993-05-29
PH25529A (en) 1991-07-24
GB8804063D0 (en) 1988-03-23
NO881044L (no) 1988-09-12
JPS63243081A (ja) 1988-10-07
PT86934B (pt) 1992-05-29
HUT50336A (en) 1990-01-29
IE61122B1 (en) 1994-10-05
AU595099B2 (en) 1990-03-22
AU1237888A (en) 1988-09-08
ES2037822T3 (es) 1993-07-01
DK113088A (da) 1988-09-11
FI881087A (fi) 1988-09-11
PT86934A (pt) 1988-04-01
EP0282236A1 (en) 1988-09-14
IL85564A0 (en) 1988-08-31
EP0282236B1 (en) 1991-12-11
GB8705574D0 (en) 1987-04-15
ZA881350B (en) 1988-12-28
JPH0688991B2 (ja) 1994-11-09
HU202231B (en) 1991-02-28
DD271703A5 (de) 1989-09-13
IE880507L (en) 1988-09-10
FI87778B (fi) 1992-11-13
DK113088D0 (da) 1988-03-02
CA1337345C (en) 1995-10-17
NO881044D0 (no) 1988-03-09
NZ223813A (en) 1990-11-27
IL85564A (en) 1992-05-25
NO174421B (no) 1994-01-24
GR3003324T3 (en) 1993-02-17
KR880011151A (ko) 1988-10-26
DK175310B1 (da) 2004-08-16
AR245707A1 (es) 1994-02-28
ATE70271T1 (de) 1991-12-15

Similar Documents

Publication Publication Date Title
NO174421C (no) Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelsen 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)-dibenzo(b,f)(1,4)tiazepin
NO168771C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)dibenzo(b,f)-(1,4)-tiazepin og farmasoeytisk akseptable salter derav
NO177387C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser
FI880941A (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
FI104074B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-[2-(3-karboksifenyylikarbamoyyli)pyrrolidin-4-yylitio]karbapeneemijohdannaisten valmistamiseksi
NO163566C (no) 1,5-benzothiazepinderivater som er anvendelige som utgangsmaterialer ved fremstilling av nye, terapeutisk aktive 8-klor-1,5-benzothiazepinderivater.
NO954489D0 (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive pyrimidinforbindelser
FI102756B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksi
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
RO92610A (ro) Procedeu de preparare a unor 2-(2'-alchil-benzoil)-1,3-ciclohexandione
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO171853C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO166283C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(5-amino-1,2,4-tiadiazol-3-yl)-2(z)-substituertoksyiminoacetamido)-3-(heterocyclylmetyl)-3-cefem-4-karboksylsyrederivater.
PT85128A (en) Process for the preparation of pharmaceutical compounds containing as active ingredient 4-(1-methyl-4-piperydilidene)-4h-benzo-(4,5)-cyclohepta(1,2-b)thiophene-10(9h)-one
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI893936A0 (fi) Menetelmä terapeuttisesti aktiivisten yhdisteiden valmistamiseksi sekä välituotteita
NO174892C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
NO171065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO169962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
IE39103B1 (en) Quaternary 6,11-dihydro-11-(3-tropanyloxy)-dibenzo (b,e) thiepin derivatives
GR3025188T3 (en) Process for the resolution of intermediates useful in the preparation of 1,5-benzothiazepines
NL193639B (nl) Farmaceutisch aanvaardbare zouten van [3S(Z)]-2[[[1-(2-aminothiazolyl-4)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy) -3-azetidinyl]amino]-2-oxoethylideen]amino]-oxy]azijnzuur.

Legal Events

Date Code Title Description
MK1K Patent expired